Remitogen
Remitogen Uses, Dosage, Side Effects, Food Interaction and all others data.
Remitogen is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers.
Trade Name | Remitogen |
Generic | Apolizumab |
Apolizumab Other Names | Apolizumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in lymphoma (non-hodgkin's), leukemia (lymphoid), and solid tumors.
How Remitogen works
Remitogen is a humanized monoclonal antibody directed against 1D10, a polymorphic determinant on the HLA-DR beta chain that is expressed on normal and neoplastic B cells. Remitogen induces complement-mediated cytotoxicity, antibody-dependent cell-mediated cytotoxicity, and apoptosis of 1D10 antigen-positive B cells in vitro.
Innovators Monograph
You find simplified version here Remitogen